The roles of antimicrobial peptides in innate host defense.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMC 2750833)

Published in Curr Pharm Des on January 01, 2009

Authors

Gill Diamond1, Nicholas Beckloff, Aaron Weinberg, Kevin O Kisich

Author Affiliations

1: Department of Oral Biology, UMDNJ-New Jersey Dental School, Newark, NJ 07101, USA. gdiamond@umdnj.edu

Articles citing this

Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res (2014) 2.11

Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog (2010) 1.76

Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog (2011) 1.40

Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23

Beta-defensins: what are they really doing in the oral cavity? Oral Dis (2011) 0.99

EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence. Infect Immun (2012) 0.98

Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface. Mol Microbiol (2010) 0.97

A shared role for RBF1 and dCAP-D3 in the regulation of transcription with consequences for innate immunity. PLoS Genet (2012) 0.95

Mucosal transmission of human immunodeficiency virus. Curr HIV Res (2012) 0.92

Antimicrobial peptides in periodontal innate defense. Front Oral Biol (2011) 0.91

Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367. Biochemistry (2010) 0.91

Nylon-3 polymers with selective antifungal activity. J Am Chem Soc (2013) 0.91

Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts. Arthritis Res Ther (2011) 0.89

Characterization of a membrane-active peptide from the Bordetella pertussis CyaA toxin. J Biol Chem (2013) 0.88

Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol (2011) 0.87

Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage. Alcohol Alcohol (2010) 0.85

Epithelial antimicrobial peptides: guardian of the oral cavity. Int J Pept (2014) 0.85

Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans. Mol Oral Microbiol (2010) 0.84

Manduca sexta moricin promoter elements can increase promoter activities of Drosophila melanogaster antimicrobial peptide genes. Insect Biochem Mol Biol (2011) 0.83

Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration. Clin Orthop Relat Res (2015) 0.82

Enhanced amphiphilic profile of a short β-stranded peptide improves its antimicrobial activity. PLoS One (2015) 0.82

Transcription profiling reveals potential mechanisms of dysbiosis in the oral microbiome of rhesus macaques with chronic untreated SIV infection. PLoS One (2013) 0.82

Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus. Antimicrob Agents Chemother (2011) 0.82

Non-conventional therapeutics for oral infections. Virulence (2015) 0.81

The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor. Infect Immun (2011) 0.81

Evidence for phenylalanine zipper-mediated dimerization in the X-ray crystal structure of a magainin 2 analogue. J Am Chem Soc (2013) 0.81

Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa. Eur Biophys J (2011) 0.80

Immune-directed support of rich microbial communities in the gut has ancient roots. Dev Comp Immunol (2014) 0.80

Interplay among subunit identity, subunit proportion, chain length, and stereochemistry in the activity profile of sequence-random peptide mixtures. J Am Chem Soc (2013) 0.80

Modulation of porcine β-defensins 1 and 2 upon individual and combined Fusarium toxin exposure in a swine jejunal epithelial cell line. Appl Environ Microbiol (2013) 0.80

Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Mol Cells (2010) 0.77

Epithelial innate immune response to Acinetobacter baumannii challenge. Infect Immun (2014) 0.77

Suppression of antimicrobial peptide expression by ureaplasma species. Infect Immun (2014) 0.77

On the role of NMR spectroscopy for characterization of antimicrobial peptides. Methods Mol Biol (2013) 0.77

CCL20 and Beta-Defensin 2 Production by Human Lung Epithelial Cells and Macrophages in Response to Brucella abortus Infection. PLoS One (2015) 0.77

Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells. J Leukoc Biol (2013) 0.77

Disulfide-stabilized helical hairpin structure and activity of a novel antifungal peptide EcAMP1 from seeds of barnyard grass (Echinochloa crus-galli). J Biol Chem (2011) 0.77

Recent Developments in Antimicrobial Polymers: A Review. Materials (Basel) (2016) 0.76

Immune activation efficacy of indolicidin is enhanced upon conjugation with carbon nanotubes and gold nanoparticles. PLoS One (2015) 0.76

Overexpression of Porcine Beta-Defensin 2 Enhances Resistance to Actinobacillus pleuropneumoniae Infection in Pigs. Infect Immun (2015) 0.76

Quasiracemate Crystal Structures of Magainin 2 Derivatives Support the Functional Significance of the Phenylalanine Zipper Motif. J Am Chem Soc (2015) 0.76

Effect of the antimicrobial peptide tritrpticin on the in vitro viability and growth of Trichomonas vaginalis. Curr Microbiol (2010) 0.76

Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells. Microbiol Spectr (2016) 0.76

Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37. J Biol Chem (2015) 0.76

Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasis. Antimicrob Agents Chemother (2014) 0.76

Synovial Fluid C-reactive Protein as a Diagnostic Marker for Periprosthetic Joint Infection: A Systematic Review and Meta-analysis. Chin Med J (Engl) (2016) 0.75

The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro. Front Microbiol (2017) 0.75

Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis. Front Chem (2017) 0.75

FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6. Infect Immun (2016) 0.75

A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes. PLoS One (2016) 0.75

Multiple Functions of the New Cytokine-Based Antimicrobial Peptide Thymic Stromal Lymphopoietin (TSLP). Pharmaceuticals (Basel) (2016) 0.75

Nicotinic alpha 7 receptor expression and modulation of the lung epithelial response to lipopolysaccharide. PLoS One (2017) 0.75

Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design. Front Neurosci (2017) 0.75

Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections. Acta Biomater (2016) 0.75

Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity. Sci Rep (2017) 0.75

Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action. PLoS Pathog (2017) 0.75

The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectants. J Microbiol (2017) 0.75

[Beyond antibiotic therapy - Future antiinfective strategies - Update 2017]. Unfallchirurg (2017) 0.75

Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity. Viruses (2017) 0.75

Articles cited by this

(truncated to the top 100)

Dendritic cells and the control of immunity. Nature (1998) 56.54

Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol (2005) 13.69

Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11

The host defense of Drosophila melanogaster. Annu Rev Immunol (2007) 10.75

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 10.15

Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01

Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A (1987) 8.53

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86

Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta (1983) 7.71

Antimicrobial factors of normal tissues and fluids. Bacteriol Rev (1957) 7.64

Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev (2003) 6.57

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 6.49

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol (2004) 6.35

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19

Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16

Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99

Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature (1981) 5.66

Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20

The preference of tryptophan for membrane interfaces. Biochemistry (1998) 5.10

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med (2000) 4.68

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science (2002) 4.45

Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J (2005) 4.36

Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem (1980) 4.35

The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol (2006) 4.29

The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol (2000) 4.10

A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90

Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85

IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol (2004) 3.84

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature (2000) 3.81

Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J (2001) 3.80

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78

Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science (2002) 3.73

ANTIBACTERIAL AND ENZYMIC BASIC PROTEINS FROM LEUKOCYTE LYSOSOMES: SEPARATION AND IDENTIFICATION. Science (1963) 3.53

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51

Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci U S A (1988) 3.51

Action of antimicrobial peptides: two-state model. Biochemistry (2000) 3.49

Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41

Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity (2006) 3.39

Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett (1995) 3.21

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19

An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16

Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3.13

Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother (1997) 3.12

Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med (2001) 3.11

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000) 3.09

Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet (2002) 3.01

Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00

Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00

Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol (1999) 2.96

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med (1998) 2.84

Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78

Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science (1991) 2.71

Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol (1997) 2.68

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 2.55

Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol (2006) 2.53

The relationship between peptide structure and antibacterial activity. Peptides (2003) 2.51

Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50

The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol (2003) 2.50

Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45

A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol (2004) 2.40

Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother (2004) 2.34

Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A (2003) 2.32

Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol (2000) 2.32

Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29

Defensins in innate antiviral immunity. Nat Rev Immunol (2006) 2.26

Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A (1988) 2.24

Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24

X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys J (1995) 2.24

Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect Immun (1996) 2.20

Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol (2007) 2.19

Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry (1998) 2.18

The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol (2003) 2.15

Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog (2007) 2.14

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14

Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta (2006) 2.14

Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci (2006) 2.12

Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother (2005) 2.11

Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A (2007) 2.10

Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst Fibros (2007) 2.07

Innate immunity and the normal microflora. Immunol Rev (2000) 2.04

Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J (1996) 2.03

Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci U S A (2004) 2.00

An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol (2007) 1.97

Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology (2004) 1.96

Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry (1995) 1.93

Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta (2006) 1.93

Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol (2004) 1.91

Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun (2003) 1.90

ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res (2004) 1.88

Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol (2003) 1.88

Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother (2006) 1.87

Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules. J Natl Cancer Inst (2000) 1.85

New insights into the mechanisms of vitamin D action. J Cell Biochem (2003) 1.79

Articles by these authors

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 2.55

Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol (2004) 2.16

Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A (2007) 2.10

An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One (2010) 2.08

Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol (2006) 1.67

Role of bacteria in health and disease of periodontal tissues. Periodontol 2000 (2006) 1.61

Minimally invasive percutaneous management of large bladder stones with a laparoscopic entrapment bag. J Endourol (2013) 1.21

A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J Immunol (2002) 1.13

Determinants of protection among HIV‐exposed seronegative persons: an overview. J Infect Dis (2010) 1.13

Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol (2008) 1.09

Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin Chem (2007) 1.01

Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am J Respir Cell Mol Biol (2002) 1.00

Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells. Cell Cycle (2012) 0.97

Characterizing traditionally defined periodontal disease in HIV+ adults. Community Dent Oral Epidemiol (2009) 0.97

The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes. Immunology (2011) 0.97

Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides (2009) 0.95

Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1ß and lactoferrin. PLoS One (2011) 0.95

Mucosal transmission of human immunodeficiency virus. Curr HIV Res (2012) 0.92

Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor beta in neutrophils. J Biol Chem (2003) 0.92

Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92

Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem (2010) 0.88

Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication. J Virol (2014) 0.87

Anti-tuberculosis activity of α-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Protein Pept Lett (2011) 0.87

Membrane damage and repair in primary monocytes exposed to human β-defensin-3. J Leukoc Biol (2012) 0.86

Human β-defensin 3 peptide is increased and redistributed in Crohn's ileitis. Inflamm Bowel Dis (2013) 0.84

Proteomic signatures of human oral epithelial cells in HIV-infected subjects. PLoS One (2011) 0.84

A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults. AIDS Res Hum Retroviruses (2011) 0.83

Copy Number Variation within Human β-Defensin Gene Cluster Influences Progression to AIDS in the Multicenter AIDS Cohort Study. J AIDS Clin Res (2012) 0.83

Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells. J Virol (2013) 0.83

Isolation of T cells from mouse oral tissues. Biol Proced Online (2014) 0.83

Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal (2012) 0.83

Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration. Clin Orthop Relat Res (2015) 0.82

Detection of HBD1 peptide in peripheral blood mononuclear cell subpopulations by intracellular flow cytometry. Peptides (2003) 0.82

Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons. Immunology (2013) 0.81

Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects. Epigenetics (2013) 0.80

Occurrence of spontaneous periodontal disease in the SAMP1/YitFc murine model of Crohn disease. J Periodontol (2014) 0.79

Fusobacterium nucleatum and human beta-defensins modulate the release of antimicrobial chemokine CCL20/macrophage inflammatory protein 3α. Infect Immun (2011) 0.79

Bacterial colonization and beta defensins in the female genital tract in HIV infection. Curr HIV Res (2012) 0.78

Effect of Nadir CD4+ T cell count on clinical measures of periodontal disease in HIV+ adults before and during immune reconstitution on HAART. PLoS One (2013) 0.78

Human β-defensin-3 structure motifs that are important in CXCR4 antagonism. FEBS J (2013) 0.77

Genomics for key players in the N cycle from guinea pigs to the next frontier. Methods Enzymol (2011) 0.77

Hairpin ribozyme-antisense RNA constructs can act as molecular Lassos. Nucleic Acids Res (2008) 0.75

Proteomic and bioinformatic profile of primary human oral epithelial cells. J Proteome Res (2012) 0.75

Protein modification by dicarbonyl molecular species in neurodegenerative diseases. J Amino Acids (2011) 0.75